学術・PMS・薬事>薬事

メディカル>医薬品メーカー 会員属性などに応じ、当該求人をビズリーチ上で閲覧された際に内容が異なる場合があります


POSITION SUMMARY:
Lead Japanese regulatory strategy and target labeling in J-CDT, and share the information to the Global Regulatory Team (GRT) Lead CTD Preparation Team for J-NDA submission Lead Japanese Health Authority (HA) response such as PMDA consultation preliminary meeting, MHLW meeting related the development of compound, Day review for J-CTN regarding development plan and submission Negotiate with HAs regarding development compound


PRINCIPAL RESPONSIBILITIES:

Input regulatory strategy to J-CDT May serve as a regulatory lead at J-CDT Participates in GRT to provide inputs on Japanese regulatory strategy and target labeling Refines Japanese regulatory strategy as new data becomes available and re-assesses as necessary Provides input into strategy with respect to clinical study design for local studies.

(Provides input into global clinical studies with Japanese requirement if needed) Develops and updates contingency plans for regulatory strategies as they pertain to Japan Provides input on implications for regulatory strategy through participation in J-CDT Reviews and provides regulatory input on Japanese Investigator Initiated Proposals as required Within the context of the global strategy, determines timing, appropriate Japanese strategy and content for Japanese HA meetings of development products.

Provides input on study design, conduct, and need for any additional studies for Japan Provides regulatory strategic and operational support for products by interacting with project teams, reviewing protocols, maintaining CTNs and NDAs (prepare and submit regulatory submissions, protocol amendments, etc) etc.

Write and revise disease-specific Japanese target labels based on attributes from Japanese Target Product Profile (TPP) and linked to the Clinical Development Plan and the Regulatory Strategy for Japan Labeling Co-lead the Japanese Labeling Working Group in making strategic decisions, including creation of Labeling strategy Reviews labeling to ensure adequate documentation supports the Japanese labeling text Ensure the target label and labeling strategy conforms to the Regulatory Strategy for Japan Responsible for the contribution to development of Japanese labeling strategy and backup strategies for label negotiation for Japan Write and revise Japan target labels during development that are aligned to clinical, commercial and regulatory strategies and in response to evolving data CTN/NDA Preparation & submission Provide input to and be accountable for the preparation of dossiers for submission to HA (NDA CTN) Lead the CTD Preparation Team to prepare Common Technical Document (CTD) for Japan Defines, generates and submits appropriate data-driven responses to Japanese HA questions Manages lifecycle management submissions for additional indication etc.

with clinical study for Japan.

Provides input to J-CT to define submission plans including timing for new CTN and CTN amendments and HA reporting requirements; CTN submission dossier content, scope and timing Provides input to and reviews submission documents to ensure they accurately answer the questions being posed and are consistent with HA commitment for Japan Support cross-functional team (J-CT) to respond Day review and amendment for J-CTN Response to HAs Lead strategy for providing responses to PMDA/MHWL questions (ensure alignment with global strategy by collaboration with responsible function for the topic) Ensures that responses to PMDA/MHLW questions are handled in a timely manner and in line with the approved product strategy Lead cross-functional team (CTD Preparation Team) to prepare HA responses.

Participates in J-CDT/CTD Preparation Team to ensure appropriate and timely responses to HA questions. Provides clarification regarding HA questions and provides input to the strategy for responding to HA questions Relationship with Global Team Participates in project related GRT meetings by providing Japanese input if required Participates in CDT meeting to provide input on Japanese regulatory strategy if required Communicate with Global Regulatory Leader APRA Liaison to exchange information Interacts with APRA Liaison to facilitate execution of regulatory strategy (e.g.

for co-development with Asia-Pacific countries) Regulatory Advice Supports all regulatory activities associated with the registration and maintenance of new products and line extensions (e.g.

additional indications) Provides guidance and support to J-CDT on regulatory issues Exchanges information on Japanese regulation with appropriate person, e.g. GRL, APRA liaison RA Organizational Management Participates in Regulatory Development Department ext-LT to discuss and manage issues/improvement related to to department and RCL work Support RA Professionals

EDUCATION, EXPERIENCE &


SKILL REQUIREMENTS:
・ Minimum of bachelor's degree or equivalent in pharmacy or life-science or health-related discipline ・ Minimum of 6 years of overall experience in R&D in pharmaceutical industry (including 2 years of regulatory experience) or in health authorities OR Masters/PharmD and 4 years, PhD and 2 years ・ Leadership and contribution to drug development strategies ・ Experience in HAs interactions ・ Knowledge of regulations in Japan ・ Good verbal and written communications skills in Japanese and business-level English skills ・ Can develop and maintain excellent working relationships, work successfully within a team environment and as an individual contributor. ・ Proactive team player, able to take charge and follow-through. Achievement-oriented with a high degree of flexibility and ability to adapt to a changing regulatory environment. ・ Flexibility to accommodate early morning/evening meetings teleconferences with different time zones, especially if there is an important topic related to Japan development plan.

---